| Safety of Once-weekly Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes |
3 |
| Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer |
3 |
| Point-of-care ultrasound: Coming soon to primary care? |
3 |
| Osteoporosis: A quick update |
2 |
| Can medical scribes improve quality measure documentation? |
2 |
| Q / What are the risks of long-term PPI use for GERD symptoms in patients > 65 years? |
2 |
| Nonpharmacologic treatment of chronic pain: What works? |
2 |
| An Overview of the Burden of Illness and the Role of Once-Weekly Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Type 2 Diabetes |
1 |
| The Pharmacokinetic Properties of Glucagon-like Peptide-1 Receptor Agonists and Their Mode and Mechanism of Action in Patients with Type 2 Diabetes |
1 |
| Combine these screening tools to detect bipolar depression |
1 |
| CASE REPORT |
1 |
| Obesity: When to consider surgery |
1 |
| Neonatal hyperbilirubinemia: An evidence-based approach |
1 |
| Childhood adversity & lifelong health: From research to action |
1 |
| Periprocedural management of oral anticoagulation: When and how to hit pause |
1 |
| Cognitive bias: Its influence on clinical diagnosis In a busy practice, it's helpful to be aware of specific psychological tendencies that influence diagnostic reasoning and can lead to error |
1 |
| The case for behavioral health integration into primary care |
1 |
| Allergy immunotherapy: Who, what, when ... and how safe? |
1 |
| The benefits of a standardized approach to opioid prescribing |
1 |
| ACL injury: How do the physical examination tests compare? |
1 |
| The agitated patient: Steps to take, how to stay safe |
1 |
| Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease |
1 |
| Dyspnea and Hyperinflation in Chronic Obstructive Pulmonary Disease: Impact on Physical Activity |
1 |
| Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management |
1 |
| When guideline treatment of asthma fails, consider a macrolide antibiotic |
1 |
| A patient-centered approach to tapering opioids |
1 |
| Long-term Treatment of Gout: New Opportunities for Improved Outcomes |
1 |
| Identification and Management of Insomnia in Alzheimer's Disease |
1 |
| Inpatient antibiotic resistance: Everyone's problem |
1 |
| Schizophrenia: Ensuring an accurate Dx, optimizing treatment |
0 |
| Does fish oil during pregnancy help prevent asthma in kids? |
0 |
| Mild cough . wheezing . loud heart sounds . Dx? |
0 |
| Elevated serum alkaline phosphatase . generalized pruritus . Dx? |
0 |
| The evidence for herbal and botanical remedies, Part 1 |
0 |
| Heart failure treatment: Keeping up with best practices |
0 |
| The evidence for herbal and botanical remedies, Part 2 |
0 |
| Making the Diagnosis of Cluster Headache |
0 |
| Diabetes Management Update: Individualizing Treatment |
0 |
| Evolving Issues in Statin Selection |
0 |
| Patient-Centric Care of Diarrhea-Predominant Irritable Bowel Syndrome |
0 |
| Efficacy and Safety of Naproxen vs Opioids for the Treatment of Musculoskeletal Pain |
0 |
| Chronic Kidney Disease in Type 2 Diabetes: Optimizing Glucose-Lowering Therapy |
0 |
| A Practical Approach to Managing Heart Failure in Type 2 Diabetes Mellitus |
0 |
| Approaches to Increase Colorectal Cancer Screening Rates: Key Information for the Primary Care Provider |
0 |
| Weight Management for Patients with Type 2 Diabetes: Impact of Newer Antidiabetic Therapies on Body Weight |
0 |
| Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy |
0 |
| Managing Patient Pain: A Focus on NSAID OTC Formulations for Relief of Musculoskeletal and Other Common Sources Pain |
0 |
| From Randomized Controlled Trials to the Real World: Putting Evidence into Context |
0 |
| Individualizing Treatment with Statin Therapy |
0 |
| Differentiating Among the SGLT-2 Inhibitors: Considering cardiovascular and Other Safety Outcomes |
0 |
